Bronte Capital Management’s Herbalife HLF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.25M | Sell |
323,386
-616,540
| -66% | -$8.5M | 0.46% | 27 |
|
|
2026
Q1 | $13.8M | Sell |
939,926
-180,249
| -16% | -$2.94M | 1.37% | 17 |
|
|
2025
Q4 | $14.4M | Sell |
1,120,175
-238,814
| -18% | -$2.53M | 1.44% | 16 |
|
|
2025
Q3 | $12.8M | Sell |
1,358,989
-864,794
| -39% | -$8.16M | 1.15% | 20 |
|
|
2025
Q2 | $21.6M | Sell |
2,223,783
-336,292
| -13% | -$2.5M | 1.7% | 14 |
|
|
2025
Q1 | $25.9M | Buy |
2,560,075
+960,907
| +60% | +$6.84M | 2.1% | 14 |
|
|
2024
Q4 | $10.7M | Sell |
1,599,168
-1,054,746
| -40% | -$7.84M | 0.84% | 18 |
|
|
2024
Q3 | $19.1M | Sell |
2,653,914
-42,694
| -2% | -$393K | 1.55% | 15 |
|
|
2024
Q2 | $28M | Sell |
2,696,608
-108,645
| -4% | -$1.09M | 2.19% | 16 |
|
|
2024
Q1 | $28.2M | Sell |
2,805,253
-297,464
| -10% | -$3.2M | 2.3% | 16 |
|
|
2023
Q4 | $47.3M | Sell |
3,102,717
-18,750
| -0.6% | -$259K | 4.23% | 9 |
|
|
2023
Q3 | $43.7M | Buy |
3,121,467
+104,567
| +3% | +$1.58M | 4.4% | 7 |
|
|
2023
Q2 | $39.9M | Buy |
3,016,900
+10,352
| +0.3% | +$141K | 3.85% | 8 |
|
|
2023
Q1 | $48.4M | Buy |
3,006,548
+368,653
| +14% | +$6.52M | 5.62% | 6 |
|
|
2022
Q4 | $39.3M | Sell |
2,637,895
-478,320
| -15% | -$8.33M | 4.95% | 6 |
|
|
2022
Q3 | $62M | Buy |
3,116,215
+119,554
| +4% | +$2.96M | 7.72% | 4 |
|
|
2022
Q2 | $61.3M | Buy |
2,996,661
+34,026
| +1% | +$841K | 7.02% | 4 |
|
|
2022
Q1 | $89.9M | Buy |
2,962,635
+207,063
| +8% | +$8.1M | 7.56% | 5 |
|
|
2021
Q4 | $113M | Buy |
2,755,572
+410,086
| +17% | +$17.1M | 7.44% | 5 |
|
|
2021
Q3 | $99.4M | Buy |
2,345,486
+91,625
| +4% | +$4.53M | 7.27% | 6 |
|
|
2021
Q2 | $119M | Buy |
2,253,861
+133,302
| +6% | +$6.63M | 8.47% | 5 |
|
|
2021
Q1 | $94.1M | Buy |
2,120,559
+59,314
| +3% | +$2.93M | 10.67% | 4 |
|
|
2020
Q4 | $99M | Hold |
2,061,245
| – | – | 15.65% | 2 |
|
|
2020
Q3 | $93M | Sell |
2,061,245
-22,617
| -1% | -$1.11M | 16.39% | 2 |
|
|
2020
Q2 | $93.7M | Sell |
2,083,862
-230,289
| -10% | -$8.94M | 16.44% | 2 |
|
|
2020
Q1 | $67.5M | Buy |
2,314,151
+784,759
| +51% | +$29.2M | 11.05% | 4 |
|
|
2019
Q4 | $72.9M | Buy |
1,529,392
+52,075
| +4% | +$2.26M | 14.14% | 3 |
|
|
2019
Q3 | $55.9M | Buy |
1,477,317
+405,473
| +38% | +$15.8M | 15.47% | 2 |
|
|
2019
Q2 | $45.8M | Buy |
1,071,844
+128,716
| +14% | +$6.09M | 16.33% | 3 |
|
|
2019
Q1 | $50M | Buy |
943,128
+6,383
| +0.7% | +$367K | 18.75% | 2 |
|
|
2018
Q4 | $55.2M | Buy |
+936,745
| New | +$51.7M | 22.03% | 2 |
|
Other funds holding HLF
BG
ROIC
SP
Bronte Capital Management's HLF Position: Q2 2026 in Review
Bronte Capital Management reduced its Herbalife (HLF) stake by 66% in Q2 2026, selling an estimated $8.5M and leaving 323,386 shares worth $4.25M. The position accounts for 0.46% of the portfolio, ranked #27.
Bronte Capital Management first reported a position in HLF in Q4 2018 and has held it in 31 quarters since. The position peaked at $119M in Q2 2021. 235 funds tracked by Wall St. Rank hold HLF as of Q2 2026.
- Bronte Capital Management held 323,386 shares of Herbalife worth $4.25M as of Q2 2026.
- Bronte Capital Management sold 616,540 Herbalife shares in Q2 2026, an estimated $8.5M.
- Herbalife made up 0.46% of Bronte Capital Management's portfolio in Q2 2026, its #27 holding.
- Bronte Capital Management first reported a position in Herbalife in Q4 2018 and has held it in 31 quarters since.
- Bronte Capital Management's Herbalife position peaked at $119M in Q2 2021.
- 235 funds tracked by Wall St. Rank held Herbalife as of Q2 2026.
Based on Bronte Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.